Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Tag:
Shukra Pharma healthcare innovation
Shukra Pharmaceuticals Expands into MedTech Following Landmark NSE Listing
Breaking News
Dose Daily News Bureau
-
August 16, 2026
Shukra Pharmaceuticals has officially marked a major milestone in its corporate growth journey with its new listing on the National Stock Exchange (NSE). The listing...
I want in
I've read and accept the
Privacy Policy
.
ViiV Healthcare Advances HIV Care with Breakthrough Long-Acting Injectable Data at AIDS 2026
Dose Daily News Bureau
-
August 19, 2026
Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India
Breaking News
Optimus Pharma Secures Regulatory Approval for Non-Steroidal Tapinarof Cream to Treat Plaque Psoriasis
Breaking News
Enhertu Shows Better Results Than Standard Treatment in Lung Cancer Trial
Breaking News
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Advanced Lung Cancer
Breaking News
Argenx’s Efgartigimod Clears Phase 3, Bringing New Hope for Autoimmune Myositis
Breaking News
×